Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
A Pilot Trial to Evaluate the Effectiveness of Navigation, Interactive Web Education, or the Combination of Both to Promote Guideline-Concordant Colorectal Cancer Surveillance Care
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
This pilot clinical trial looks at whether patient navigation services, an interactive web education intervention, called Current Together After Cancer (CTAC), or both navigation and CTAC works to improve the uptake of surveillance in patients with stage I-III colorectal cancer (CRC). Post-treatment surveillance is critical to detect recurrence early, yet many CRC survivors do not receive recommended surveillance care. Surveillance is a complex process that includes laboratory tests, cross-sectional imaging, and endoscopic procedures. Patient navigation services, interactive web education, or a combination of both may improve surveillance care for patients with stage I-III colorectal cancer.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * Age ≥ 18 due to disease and clinic population * Stage I-III CRC survivor within 3 months post-surgical resection * Being seen at a participating clinic * Ability to understand and complete surveys in English
Study sites (2)
WA
- Benaroya Research Institute at Virginia Mason · Seattle, WA 98101Vlad Simianu, MD, MPH, FACS, FASCRS · Principal investigatorMore trials in Seattle
- Fred Hutch/University of Washington Cancer Consortium · Seattle, WA 98109Ari Bell-Brown · Study contact · 206-667-7624 · abellbro@fredhutch.orgRachel B. Issaka, MD, MAS · Principal investigatorMore trials in Seattle